恩格莱丁通过通过LCN2/CXCL10信号通路调节微质极化来缓解类似抑郁的行为
Jie Zhang1, Zheng Song2, Yanchao Huo2
1Department of Radiology, Binzhou Medical University Hospital, Binzhou, Shandong, P. R. China.
Journal of cellular and molecular medicine
|April 10, 2024
概括
恩格莱丁是一种天然化合物,通过减少炎症和通过LCN2/CXCL10通路改变微质极化,减轻小鼠的抑郁症类行为. 这表明格林素是潜在的抑郁治疗药物,向微质细胞.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 微质极化和炎症是抑郁症的核心原因.
- 抗炎化合物格列丁在抑郁症中的作用尚未被探索.
- 慢性压力社会失败压力 (CSDS) 是抑郁症的一个相关模型.
研究的目的:
- 为了研究格莱的抗抑郁机制.
- 在抑郁症模型中检查格列对微质偏振的影响.
- 为了确定参与格列治疗作用的分子通路.
主要方法:
- 利用CSDS小鼠模型诱导类似抑郁症的行为.
- 评估行为变化,脑成像 (T1WI,T2WI,扩散张力成像) 和分子标记 (细胞因子,微质偏极化).
- 研究了LCN2/CXCL10信号轴的作用,使用腺相关病毒介导的基因过度表达.
主要成果:
- 在CSDS小鼠中,Engeletin治疗显著降低了类似抑郁症的行为.
- 恩格莱逆转了前额皮层扩散和T2值中CSDS诱导的变化.
- 恩格莱丁抑制了促炎性细胞因子的产生,M1微质极化,并调节了LCN2/CXCL10通路.
结论:
- 恩格莱丁通过通过LCN2/CXCL10通路调节微质极化,产生抗抑郁作用.
- 微质两极分化是格莱抗抑郁作用的关键相关因子.
- 恩格莱丁代表了针对微质通路的抑郁症的有希望的治疗候选者.
相关概念视频
G-protein Coupled Receptors
118.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.6K
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227


